These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11179303)

  • 1. Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga-toxigenic Escherichia coli.
    Paton JC; Rogers TJ; Morona R; Paton AW
    Infect Immun; 2001 Mar; 69(3):1389-93. PubMed ID: 11179303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues.
    Karmali MA
    J Infect Dis; 2004 Feb; 189(3):355-9. PubMed ID: 14745691
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against Shiga-Toxigenic Escherichia coli by Non-Genetically Modified Organism Receptor Mimic Bacterial Ghosts.
    Paton AW; Chen AY; Wang H; McAllister LJ; Höggerl F; Mayr UB; Shewell LK; Jennings MP; Morona R; Lubitz W; Paton JC
    Infect Immun; 2015 Sep; 83(9):3526-33. PubMed ID: 26099582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga toxin-producing Escherichia coli infection.
    Thorpe CM
    Clin Infect Dis; 2004 May; 38(9):1298-303. PubMed ID: 15127344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refinement of a therapeutic Shiga toxin-binding probiotic for human trials.
    Pinyon RA; Paton JC; Paton AW; Botten JA; Morona R
    J Infect Dis; 2004 May; 189(9):1547-55. PubMed ID: 15116289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli.
    Talbot UM; Paton JC; Paton AW
    Infect Immun; 2005 Jul; 73(7):4432-6. PubMed ID: 15972544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.
    Bielaszewska M; Friedrich AW; Aldick T; Schürk-Bulgrin R; Karch H
    Clin Infect Dis; 2006 Nov; 43(9):1160-7. PubMed ID: 17029135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2.
    Smith MJ; Teel LD; Carvalho HM; Melton-Celsa AR; O'Brien AD
    Vaccine; 2006 May; 24(19):4122-9. PubMed ID: 16551486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.
    Nishikawa K; Matsuoka K; Kita E; Okabe N; Mizuguchi M; Hino K; Miyazawa S; Yamasaki C; Aoki J; Takashima S; Yamakawa Y; Nishijima M; Terunuma D; Kuzuhara H; Natori Y
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7669-74. PubMed ID: 12032341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence profiles of Shiga toxin 2e-producing Escherichia coli isolated from healthy pig at slaughter.
    Zweifel C; Schumacher S; Beutin L; Blanco J; Stephan R
    Vet Microbiol; 2006 Oct; 117(2-4):328-32. PubMed ID: 16872761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans.
    Paton AW; Srimanote P; Woodrow MC; Paton JC
    Infect Immun; 2001 Nov; 69(11):6999-7009. PubMed ID: 11598075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections.
    Serna A; Boedeker EC
    Curr Opin Gastroenterol; 2008 Jan; 24(1):38-47. PubMed ID: 18043231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiple protocol to improve diagnosis and isolation of Shiga toxin-producing Escherichia coli from human stool specimens.
    Shelton DR; Karns JS; Park CH
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):7-10. PubMed ID: 18550318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga toxin-producing Escherichia coli in healthy young beef steers from Argentina: prevalence and virulence properties.
    Meichtri L; Miliwebsky E; Gioffré A; Chinen I; Baschkier A; Chillemi G; Guth BE; Masana MO; Cataldi A; Rodríguez HR; Rivas M
    Int J Food Microbiol; 2004 Nov; 96(2):189-98. PubMed ID: 15364473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
    Wickham ME; Lupp C; Mascarenhas M; Vazquez A; Coombes BK; Brown NF; Coburn BA; Deng W; Puente JL; Karmali MA; Finlay BB
    J Infect Dis; 2006 Sep; 194(6):819-27. PubMed ID: 16941350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].
    Ibarra C; Goldstein J; Silberstein C; Zotta E; Belardo M; Repetto HA
    Arch Argent Pediatr; 2008 Oct; 106(5):435-42. PubMed ID: 19030644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and assessment of globotriose-chitosan conjugate, a novel inhibitor of shiga toxins produced by Escherichia coli.
    Li X; Wu P; Cheng S; Lv X
    J Med Chem; 2012 Mar; 55(6):2702-10. PubMed ID: 22372889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome.
    Goldwater PN
    Expert Rev Anti Infect Ther; 2007 Aug; 5(4):653-63. PubMed ID: 17678428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabry disease in mice protects against lethal disease caused by Shiga toxin-expressing enterohemorrhagic Escherichia coli.
    Cilmi SA; Karalius BJ; Choy W; Smith RN; Butterton JR
    J Infect Dis; 2006 Oct; 194(8):1135-40. PubMed ID: 16991089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.